BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 18, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 30, 2013
View Archived Issues
Trametinib dimethyl sulfoxide plus gemcitabine does not improve outcomes in pancreatic cancer
Read More
Results presented from phase II trial of axitinib in hepatocellular carcinoma
Read More
Bristol-Myers Squibb reviews progress of fourth quarter 2012
Read More
Algeta begins research program on epratuzumab-based targeted thorium conjugate
Read More
Phase III APEX study to be expanded into China
Read More
AiCuris passes enrollment milestone in phase II pritelivir study
Read More
CNRS discloses novel antibodies for cancer and other disorders
Read More
Kalvista Pharmaceuticals synthesizes new plasma kallikrein inhibitors
Read More
New PDE2A/PDE10A inhibitors disclosed by Janssen Pharmaceutical
Read More
Japanese group divulges new mraY inhibitors for bacterial infections
Read More
New antibacterial cephem compounds reported by Shionogi & Co.
Read More
Shionogi & Co. presents novel agents for HIV
Read More
Combination of luminespib and capecitabine well tolerated
Read More
Results from the first of two phase III tavaborole trials reported
Read More
Acceleron begins phase II study of ACE-536 for anemia in MDS
Read More
4-Antibody and the Ludwig Institute expand oncology antibody program
Read More
Prosensa's Duchenne muscular dystrophy products achieve orphan drug status
Read More
IRL-1620 demonstrates neuroprotection in cerebral ischemia model
Read More
OncoPep begins phase I/IIa trial of multipeptide vaccine in smoldering multiple myeloma
Read More
FDA clears IND application for ICT-140
Read More
FDA approves Kynamro for homozygous familial hypercholesterolemia
Read More
FDA advisory committee recommends approval of olodaterol for COPD
Read More
Kissei seeks Japanese approval of dexrazoxane for use in anthracycline extravasation
Read More
OrbeShield granted fast track designation for gastrointestinal ARS
Read More
ElMindA and Purdue Pharma establish research agreement in pain
Read More
Genentech licenses rights to Afraxis compounds
Read More
Biotecnol and Chiome to codevelop antibodies for cancer
Read More
